- Home
- RCKT vs WLDN Comparison
RCKT vs WLDN Comparison
Compare RCKT & WLDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- WLDN
- Stock Information
- Founded
- RCKT 1999
- WLDN 1964
- Country
- RCKT United States
- WLDN United States
- Employees
- RCKT N/A
- WLDN N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- WLDN Military/Government/Technical
- Sector
- RCKT Health Care
- WLDN Consumer Discretionary
- Exchange
- RCKT Nasdaq
- WLDN Nasdaq
- Market Cap
- RCKT 764.5M
- WLDN 745.9M
- IPO Year
- RCKT N/A
- WLDN 2006
- Fundamental
- Price
- RCKT $2.77
- WLDN $53.89
- Analyst Decision
- RCKT Buy
- WLDN Strong Buy
- Analyst Count
- RCKT 11
- WLDN 2
- Target Price
- RCKT $21.77
- WLDN $49.00
- AVG Volume (30 Days)
- RCKT 7.4M
- WLDN 167.5K
- Earning Date
- RCKT 05-08-2025
- WLDN 05-08-2025
- Dividend Yield
- RCKT N/A
- WLDN N/A
- EPS Growth
- RCKT N/A
- WLDN 79.39
- EPS
- RCKT N/A
- WLDN 1.68
- Revenue
- RCKT N/A
- WLDN $595,695,000.00
- Revenue This Year
- RCKT N/A
- WLDN N/A
- Revenue Next Year
- RCKT N/A
- WLDN $12.13
- P/E Ratio
- RCKT N/A
- WLDN $31.95
- Revenue Growth
- RCKT N/A
- WLDN 12.40
- 52 Week Low
- RCKT $2.19
- WLDN $27.19
- 52 Week High
- RCKT $26.98
- WLDN $54.49
- Technical
- Relative Strength Index (RSI)
- RCKT 27.94
- WLDN 85.58
- Support Level
- RCKT $2.19
- WLDN $52.41
- Resistance Level
- RCKT $2.67
- WLDN $52.04
- Average True Range (ATR)
- RCKT 0.54
- WLDN 1.60
- MACD
- RCKT -0.45
- WLDN 0.43
- Stochastic Oscillator
- RCKT 11.72
- WLDN 94.00
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.